RBC Analyst Updates Top 40 Domestic Stock Picks List, Adds Iamgold and Aecon, Removes Cenovus and OceanaGold.
PorAinvest
lunes, 7 de julio de 2025, 8:08 am ET1 min de lectura
CVE--
Goldman Sachs' Briefings report highlighted the current rally's unloved nature, citing moderate hedge fund positioning and strong passive flows from corporate buybacks and retail 401(k) buying. Scotiabank's bullishness on Canadian equities relative to the U.S. has almost disappeared [2].
Eli Lilly and Company (NYSE:LLY) remains one of the 13 best blue-chip stocks to buy, according to analysts. RBC Capital Markets reiterated that the company’s upcoming TRAILBLAZER-3 trial data on Kisunla could unlock significant value in the Alzheimer’s treatment market. The research firm is optimistic that the trial will deliver positive results, given prior evidence that beta-amyloid therapies have been effective in earlier stages of the disease. The firm expects the company to generate $4 billion in additional US sales if the treatment is applied to just 2.5% of the estimated 15 million eligible patients. Eli Lilly has already secured marketing authorization for Kisunla from the Australian Therapeutic Goods Administration [3].
Shell Canada Energy announced the shipment of the first liquefied natural gas (LNG) cargo from its LNG Canada facility in Kitimat, British Columbia. This facility, with Shell holding a 40% stake, is expected to play a significant role in meeting growing global energy demand, particularly in Asian markets [4]. According to Shell's LNG Outlook 2025 report, global demand for LNG could increase by around 60% by 2040, driven by economic growth in Asian countries.
Constellation Brands (NYSE:STZ) saw its first-quarter earnings fall short of expectations, but Goldman Sachs reiterated its Buy rating and $225.00 price target. Despite missing earnings estimates, the company reaffirmed its comparable fiscal year 2026 guidance and highlighted potential upside in topline growth. The stock is currently undervalued, trading at a 15% discount to alcohol industry peers on a forward P/E basis [5].
References:
[1] https://finance.yahoo.com/news/eli-lilly-lly-staring-tremendous-131926774.html
[2] https://energynews.pro/en/shell-ships-first-lng-cargo-from-its-lng-canada-facility/
[3] https://www.investing.com/news/analyst-ratings/constellation-brands-stock-holds-buy-rating-at-goldman-sachs-despite-earnings-miss-93CH-4120594
GS--
IAG--
LLY--
SHEL--
RBC Capital Markets analyst Bish Koziol updated his top 40 domestic stock picks list, adding Iamgold Corp. and Aecon Group Inc. and removing Cenovus Energy Inc. and OceanaGold Corp. His Canada Overall Top 40 Portfolio gained 5.3% in June, outperforming the S&P/TSX Composite. Goldman Sachs' Briefings report highlighted the unloved nature of the current rally, citing moderate hedge fund positioning and strong passive flows from corporate buybacks and retail 401(k) buying. Scotiabank's bullishness on Canadian equities relative to the U.S. has almost disappeared.
RBC Capital Markets analyst Bish Koziol recently updated his top 40 domestic stock picks list, adding Iamgold Corp. and Aecon Group Inc. and removing Cenovus Energy Inc. and OceanaGold Corp. [1] The Canada Overall Top 40 Portfolio gained 5.3% in June, outperforming the S&P/TSX Composite.Goldman Sachs' Briefings report highlighted the current rally's unloved nature, citing moderate hedge fund positioning and strong passive flows from corporate buybacks and retail 401(k) buying. Scotiabank's bullishness on Canadian equities relative to the U.S. has almost disappeared [2].
Eli Lilly and Company (NYSE:LLY) remains one of the 13 best blue-chip stocks to buy, according to analysts. RBC Capital Markets reiterated that the company’s upcoming TRAILBLAZER-3 trial data on Kisunla could unlock significant value in the Alzheimer’s treatment market. The research firm is optimistic that the trial will deliver positive results, given prior evidence that beta-amyloid therapies have been effective in earlier stages of the disease. The firm expects the company to generate $4 billion in additional US sales if the treatment is applied to just 2.5% of the estimated 15 million eligible patients. Eli Lilly has already secured marketing authorization for Kisunla from the Australian Therapeutic Goods Administration [3].
Shell Canada Energy announced the shipment of the first liquefied natural gas (LNG) cargo from its LNG Canada facility in Kitimat, British Columbia. This facility, with Shell holding a 40% stake, is expected to play a significant role in meeting growing global energy demand, particularly in Asian markets [4]. According to Shell's LNG Outlook 2025 report, global demand for LNG could increase by around 60% by 2040, driven by economic growth in Asian countries.
Constellation Brands (NYSE:STZ) saw its first-quarter earnings fall short of expectations, but Goldman Sachs reiterated its Buy rating and $225.00 price target. Despite missing earnings estimates, the company reaffirmed its comparable fiscal year 2026 guidance and highlighted potential upside in topline growth. The stock is currently undervalued, trading at a 15% discount to alcohol industry peers on a forward P/E basis [5].
References:
[1] https://finance.yahoo.com/news/eli-lilly-lly-staring-tremendous-131926774.html
[2] https://energynews.pro/en/shell-ships-first-lng-cargo-from-its-lng-canada-facility/
[3] https://www.investing.com/news/analyst-ratings/constellation-brands-stock-holds-buy-rating-at-goldman-sachs-despite-earnings-miss-93CH-4120594
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios